Scotia Capital’s Arbutus Biopharma ABUS Stock Holding History

Scotia Capital’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$45.5K	Hold	14,740	–	–	﹤0.01%	845
2025 Q1	$51.4K	Hold	14,740	–	–	﹤0.01%	821
2024 Q4	$48.2K	Hold	14,740	–	–	﹤0.01%	832
2024 Q3	$56.7K	Sell	14,740 -4,000	-21%	-$15.4K	﹤0.01%	814
2024 Q2	$57.9K	Sell	18,740 -10,300	-35%	-$31.8K	﹤0.01%	806
2024 Q1	$74.9K	Hold	29,040	–	–	﹤0.01%	800
2023 Q4	$72.6K	Hold	29,040	–	–	﹤0.01%	770
2023 Q3	$59K	Hold	29,040	–	–	﹤0.01%	749
2023 Q2	$66.8K	Sell	29,040 -150	-0.5%	-$345	﹤0.01%	758
2023 Q1	$88.5K	Buy	+29,190	New	+$88.5K	﹤0.01%	748
2021 Q3	–	Sell	-11,690	Closed	-$35K	–	847
2021 Q2	$35K	Hold	11,690	–	–	﹤0.01%	808
2021 Q1	$39K	Sell	11,690 -141	-1%	-$470	﹤0.01%	778
2020 Q4	$42K	Buy	11,831 +10	+0.1%	+$35	﹤0.01%	731
2020 Q3	$37K	Buy	11,821 +131	+1%	+$410	﹤0.01%	681
2020 Q2	$21K	Hold	11,690	–	–	﹤0.01%	614
2020 Q1	$12K	Buy	11,690 +40	+0.3%	+$41	﹤0.01%	626
2019 Q4	$32K	Sell	11,650 -8,000	-41%	-$22K	﹤0.01%	720
2019 Q3	$30K	Sell	19,650 -3,000	-13%	-$4.58K	﹤0.01%	707
2019 Q2	$47K	Sell	22,650 -200	-0.9%	-$415	﹤0.01%	705
2019 Q1	$82K	Hold	22,850	–	–	﹤0.01%	671
2018 Q4	$88K	Hold	22,850	–	–	﹤0.01%	626
2018 Q3	$216K	Sell	22,850 -6,200	-21%	-$58.6K	﹤0.01%	659
2018 Q2	$145K	Hold	29,050	–	–	﹤0.01%	636
2018 Q1	$145K	Hold	29,050	–	–	﹤0.01%	665
2017 Q4	$147K	Sell	29,050 -2,600	-8%	-$13.2K	﹤0.01%	660
2017 Q3	$196K	Buy	31,650 +10,150	+47%	+$62.9K	﹤0.01%	636
2017 Q2	$77K	Buy	21,500 +4,700	+28%	+$16.8K	﹤0.01%	638
2017 Q1	$55K	Sell	16,800 -18,700	-53%	-$61.2K	﹤0.01%	657
2016 Q4	$87K	Buy	+35,500	New	+$87K	﹤0.01%	633
2015 Q3	–	Sell	-11,150	Closed	-$130K	–	634
2015 Q2	$130K	Buy	+11,150	New	+$130K	﹤0.01%	612